Browsing Health Sciences by Subject "Pheroid® technology"
Now showing items 1-3 of 3
-
A clinical investigation into the bioavailability of a peroral cannabinoid-Pheroid® formulation
(North-West University (South-Africa), 2020)The therapeutic advantages of pure Cannabidiol (CBD), a phytocannabinoid isolated from the Cannabis sativa L. plant, are emphasised by the growing use of CBD in numerous conditions ranging from supplementary to the treatment ... -
The effect of Pheroid™ technology on the bioavailability of quinoline–based anti–malarial compounds in primates
(North-West University, 2012)Resistance against anti-malarial drugs remains one of the greatest obstacles to the effective control of malaria. The current first-line treatment regimen for uncomplicated P.falciparum malaria is based on artemisinin ... -
Evaluation of the oral delivery of goserelin with Pheroid® technology
(North-West University (South-Africa), 2019)The therapeutic amphiphilic peptide, goserelin, being investigated in these studies, is a type of hormone therapy generally used in addition to standard adjuvant therapy. Goserelin serves as treatment for numerous ...